Overview:
Beijing Tiantan Biological Products Co., Ltd, a listed company funded by Beijing Biological Preparations Research Institute via stripping off its main operating assets in 1998, specializes in research, production and operation of biological products like vaccine, blood preparations, diagnosis equipment, and now its share holder is China National Biotec Group. With the company development, now it has several holding subsidiaries like Changchun Qifu Biological Products Co., Ltd.
It has over 110 Biological Products，, including Hepatitis B vaccine, Polio vaccine, MMR Vaccine, Encephalitis vaccine, Influenza vaccine, Varicella vaccine, human albumin, PH4, and so on. Beijing Tiantan Biological Products Co., Ltd. is the important production base for China’s EPI vaccine.
|
Table Of Contents :
1 Profile
2 Operation
3 Revenue Structure
4 Gross Margin
5 Client and Supplier
6 Operation of Vaccine Business
Selected Charts :
- Major Shareholding Companies of Tiantan Biological and their Operating Revenue, Net Profit (Unit: RMB mln)
- Operating Revenue and Total Profit of Beijing Tiantan Biological, 2006-2011
- Revenue Breakdown of Beijing Tiantan Biological by Products, 2007-2011
- Revenue Breakdown of Beijing Tiantan Biological by Region, 2007-2011 (Unit: RMB mln)
- Gross Profit Margin of Beijing Tiantan Biological by Products, 2007-2011
- Procurement Value and Its Proportion of Top5 Suppliers of Beijing Tiantan Biological, 2007-2011
- Revenue and Its Proportion of Beijing Tiantan Biological’s Top5 Clients，2007-2011
- Top5 Clients and Their Revenue of Beijing Tiantan Biological
- Vaccine Revenue and Gross Margin of Beijing Tiantan Biological, 2007-2011（Unit：RMB mIn）
- Lot Release Quantity and Proportion of Beijing Tiantan Biological by Products, 2009-2011
|
